Entirely apart from any attorney conduct proceedings [next hearing on that, on August 10, 2010], Merck has been granted one additional day -- to Monday -- to file its 35 pages of post-trial papers challenging the Boles II Fosamax® ONJ jury verdict.
I expect a motion to set aside or reduce the jury's verdict, a motion for judgment in spite of the jury verdict, a request for a new trial and a series of appeals to the next court, on perceived errors of law, and errors in the jury instructions. 
We'll see.
I also expect that the jury's verdict will stand -- but be slightly reduced -- at some future date.
Showing posts with label Amgen Prolia FDA EMEA Merck Fosamax Bone Density Osteonecrosis Claims Femur and Jaw Jury Trial US Dist Ct NY Bellweather Case Boles June 24 July 16 19 2010. Show all posts
Showing posts with label Amgen Prolia FDA EMEA Merck Fosamax Bone Density Osteonecrosis Claims Femur and Jaw Jury Trial US Dist Ct NY Bellweather Case Boles June 24 July 16 19 2010. Show all posts
Friday, July 16, 2010
Merck's Post-Trial Motions -- In Boles II Fosamax® ONJ $8 Million Loss -- Due Monday, July 19, 2010
Subscribe to:
Posts (Atom)
